Jefferies Maintains a 'Hold' on Boston Scientific (BSX); Remaining Cloudy Until 2013...Or Later

February 3, 2012 2:21 PM EST Send to a Friend
Get Alerts BSX Hot Sheet
Price: $9.23 --0%

Rating Summary:
    8 Buy, 15 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 1 | New: 6
Trade BSX Now!
Jefferies maintains a 'Hold' on Boston Scientific (NYSE: BSX) price target cut from $6.50 to $6.00.

Jefferies analyst says, "4Q sales were again below expectations with cc growth down 8% (dn 5% ex-Neurovasc). The CRM and DES markets remain albatrosses around Boston’s neck and visibility on stabilization in these key segments is not great. Better growth isn’t expected until ’13 at the earliest. Likewise, cost savings remains a key focus but tangible leverage isn’t likely until next year."

For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.

Shares of Boston Scientific closed at $5.84 yesterday, with a 52 week range of $5.01-$7.96.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments

Related Entities

Jefferies & Co

Add Your Comment